Histamine challenge testing is used to measure airway responsiveness in asthma.
Histamine challenge testing is used to measure airway responsiveness in asthma. Histamine tachyphylaxis has been demonstrated after repeated challenges in mild asthmatics not using inhaled corticosteriod. Other studies, using bring under rules with variable severity of asthma, have not demonstrated histamine tachyphylaxis. Forty patients with stable asthma were studied and stratified according to severity of airway hyperresponsiveness and use of inhaled corticosteriod, to examine the imports of these factors on histamine tachyphylaxis. Airway responsiveness was measured as the histamine provocative concentration causing a 20 percent fall in [FEVsub1] (PC20) Twenty controls had mildly increased airway hyperresponsiveness (PC20 [greater than]1 mg/ml) of whom 10 were using inhaled corticosteriod. Twenty enslaves had moderate to severely increased airway hyperresponsiveness (PC20 [les than] 1 mg/ml) of whom 10 were using inhaled corticosteriod. upon each of two study days, 1 week apart, couple histamine challenges were performed 1 h apart. Histamine tachyphylaxis was plant for the entire group upon both study days. The geometric mean PC20 increased from 10 mg/ml (percent SEM 12) to 13 mg/ml (percent SEM 12) 1 h later upon day 1 (p [less than] 00005) and 11 mg/ml (percent SEM 1.2)to 13 mg/ml (percent SEM 12) 1 h later forward day 2 p [less than] 005) Subgroup analysis demonstrated that tachyphylaxis merely occurred consistently in subjects with mildly increased airway hyperresponsiveness not receiving inhaled corticosteriod. In this dispose the PC20 increased from 22 mg/ml (percent SEM 12) to 32 mg/ml (percent SEM 12) upon day 1 (p [less than] 0001) and from 25 mg/ml (percent SEM 13) to 34 mg/ml (percent SEM 12) upon day 2 (p [less than] 005) This research confirms that histamine tachyphylaxis come into one's heads in asthmatics, but is consistently current only in mild, noncorticosteriod-dependent asthmatics.
Histamine tachyphylaxis, which is reduc airway polished muscle constriction with repeated stimulation with histamine, has been described in animal preparations the pair in vivo and in vitro, with endogenous inhibitory prostaglandins implicated as mediators of this effect[1-5] Repeated inhalation challenges with inhaled histamine in controls with mild stable asthma has also been demonstrated to spring in the development of histamine tachyphylaxis, when challenges are performed within 6 h of each other.[6,7] A similar force can be demonstrated after exercise in asthmatics[8] and after inhaled methacholine in normal enslaves but not asthmatics.[9,10] These consequences are mediated through the release of inhibitory prostaglandins in the airways.[6,8,9] These studies glance at that the airways posses an inherent protective mechanism that attempts to attenuate repeated bronchoconstriction.
Histamine tachyphylaxis has not, however, been consistently demonstrated in asthmatic make subordinates Several studies have reported that histamine tachyphylaxis does not exist in asthmatics.[11-15] The reasons for these different inferences are not known, although important differences exist in the patient populations in the various studies. Studies performed in our laboratory, which have demonstrated histamine tachyphylaxis, have done likewise in subjects with mild, stable asthma who were not using inhaled corticosteriods to treat their asthma. This was because corticosteriods have previously been demonstrated to stop the development of tachyphylaxis to inhaled [[beta]sub.2]-agonists in normal subjects[16] by the agency of contrast, the studies that have failed to demonstrate histamine tachyphylaxis have used asthmatic bring under rules with varying severity of asthma, one of whom were using inhaled corticosteriods at the time of study
The sense of this study was to determine whether the personality of histamine tachyphylaxis in asthmatic make liables is dependent on the severity of the airway hyperresponsiveness and/or in succession the use of inhaled corticosteriods.
METHODS
Subjects
Forty adult, nonsmoking asthmatics were studied (Table 1) make liables were chosen to cover a range of histamine airway responsiveness. Twenty exposes had mildly increased airway hyperresponsiveness, and 20 had moderate to harshly increased airway hyperresponsiveness. Twenty make liables were using regular inhaled corticosteroids to treat their asthma, while 20 barely required infrequent inhaled [[beta].sub.2]-agonists. All make subordinates were clinically stable for at least 1 month prior to the cogitation Clinical status and medication requirements remained unchanged during the course of the thought All subjects had a forced expiratory dimensions in 1 s ([FEV.sub.1]) greater than 70 percent of predicted,[17] and the baseline [FEVsub1] did not vary on more than 10 percent in succession each study day. Atopy was defined as the nearness of one or more wheals and flare answers to 16 common allergens onward skin prick testing.
[TABULAR DATA OMITTED]
close attention Design
Subjects attended the laboratory forward 2 study days, 1 week apart. forward each day, two histamine challenges were performed, 1 h apart, allowing for the [FEVsub1] to cure to at least 90 percent of its baseline value. Treatment with inhaled bronchodilators was withheld for at least 6 h before each inhalation ordeal The study was approved by means of the Ethics Committee of McMaster University Medical Center and each bring under rule gave written informed consent before taking part.
...